European shares cheer Brexit trade talks extension; AstraZeneca drops

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEGBD0GA_L.jpg

The pan-European STOXX 600 index rose 0.9% after breaking a five-week winning streak to end 1% lower last week.

Leaders from both sides decided to extend talks beyond a Sunday deadline in an attempt to secure a deal to govern around $1 trillion in trade, currently free from tariffs and quotas.

The pound, battered recently by the prospect of a chaotic British exit from the bloc, rose more than 1%, weighing on London’s export-heavy firms that earn revenue in dollars.

The FTSE 100 was flat as gains in most sectors were offset by a slide in AstraZeneca. The drugmaker said over the weekend, it would buy U.S. drugmaker Alexion Pharmaceuticals (NASDAQ:ALXN) for $39 billion in its largest ever deal.